Corrigendum to ‘The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148–1159] (Annals of Oncology (2020) 31(9) (1148–1159), (S0923753420398914), (10.1016/j.annonc.2020.06.004))

  1. Mirza, M.R.
  2. Coleman, R.L.
  3. González-Martín, A.
  4. Moore, K.N.
  5. Colombo, N.
  6. Ray-Coquard, I.
  7. Pignata, S.
Journal:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Year of publication: 2021

Volume: 32

Issue: 8

Pages: 1066-1067

Type: Erratum

DOI: 10.1016/J.ANNONC.2021.05.796 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus